Subscribe to the gold package and get unlimited access to Shamra Academy
Register a new userAn open debate on SARS-CoV-2s proximal origin is long overdue
146
0
0.0
(
0
)
Authors
Rossana Segreto
Ask ChatGPT about the research
No Arabic abstract
There is a near consensus view that SARS-CoV-2 has a natural zoonotic origin; however, several characteristics of SARS-CoV-2 taken together are not easily explained by a natural zoonotic origin hypothesis. These include: a low rate of evolution in the early phase of transmission; the lack of evidence of recombination events; a high pre-existing binding to human ACE2; a novel furin cleavage site insert; a flat glycan binding domain of the spike protein which conflicts with host evasion survival patterns exhibited by other coronaviruses, and high human and mouse peptide mimicry. Initial assumptions against a laboratory origin, by contrast, have remained unsubstantiated. Furthermore, over a year after the initial outbreak in Wuhan, there is still no clear evidence of zoonotic transfer from a bat or intermediate species. Given the immense social and economic impact of this pandemic, identifying the true origin of SARS-CoV-2 is fundamental to preventing future outbreaks. The search for SARS-CoV-2s origin should include an open and unbiased inquiry into a possible laboratory origin.
rate research
Read More
One year after the onset of the COVID-19 pandemic, the origin of SARS-CoV-2 still eludes humanity. Early publications firmly stated that the virus was of natural origin, and the possibility that the virus might have escaped from a lab was discarded in most subsequent publications. However, based on a re-analysis of the initial arguments, highlighted by the current knowledge about the virus, we show that the natural origin is not supported by conclusive arguments, and that a lab origin cannot be formally discarded. We call for an opening of peer-reviewed journals to a rational, evidence-based and prejudice-free evaluation of all the reasonable hypotheses about the virus origin. We advocate that this debate should take place in the columns of renowned scientific journals, rather than being left to social media and newspapers.
We compute the allele frequencies of the alpha (B.1.1.7), beta (B.1.351) and delta (B.167.2) variants of SARS-CoV-2 from almost two million genome sequences on the GISAID repository. We find that the frequencies of a majority of the defining mutations in alpha rose towards the end of 2020 but drifted apart during spring 2021, a similar pattern being followed by delta during summer of 2021. For beta we find a more complex scenario with frequencies of some mutations rising and some remaining close to zero. Our results point to that what is generally reported as single variants is in fact a collection of variants with different genetic characteristics. For all three variants we further find some alleles with a clearly deviating time series.
Solar UV$-$C photons do not reach Earths surface, but are known to be endowed with germicidal properties that are also effective on viruses. The effect of softer UV$-$B and UV$-$A photons, which copiously reach the Earths surface, on viruses are instead little studied, particularly on single$-$stranded RNA viruses. Here we combine our measurements of the action spectrum of Covid$-$19 in response to UV light, Solar irradiation measurements on Earth during the SARS$-$CoV$-$2 pandemics, worldwide recorded Covid$-$19 mortality data and our Solar$-$Pump diffusive model of epidemics to show that (a) UV$-$B$/$A photons have a powerful virucidal effect on the single$-$stranded RNA virus Covid$-$19 and that (b) the Solar radiation that reaches temperate regions of the Earth at noon during summers, is sufficient to inactivate 63perc of virions in open$-$space concentrations (1.5 x 103 TCID50$/$mL, higher than typical aerosol) in less than 2 min. We conclude that the characteristic seasonality imprint displayed world$-$wide by the SARS$-$Cov$-$2 mortality time$-$series throughout the diffusion of the outbreak (with temperate regions showing clear seasonal trends and equatorial regions suffering, on average, a systematically lower mortality), might have been efficiently set by the different intensity of UV$-$B$/$A Solar radiation hitting different Earths locations at different times of the year. Our results suggest that Solar UV$-$B$/$A play an important role in planning strategies of confinement of the epidemics, which should be worked out and set up during spring$/$summer months and fully implemented during low$-$solar$-$irradiation periods.
A number of epidemics, including the SARS-CoV-1 epidemic of 2002-2004, have been known to exhibit superspreading, in which a small fraction of infected individuals is responsible for the majority of new infections. The existence of superspreading implies a fat-tailed distribution of infectiousness (new secondary infections caused per day) among different individuals. Here, we present a simple method to estimate the variation in infectiousness by examining the variation in early-time growth rates of new cases among different subpopulations. We use this method to estimate the mean and variance in the infectiousness, $beta$, for SARS-CoV-2 transmission during the early stages of the pandemic within the United States. We find that $sigma_beta/mu_beta gtrsim 3.2$, where $mu_beta$ is the mean infectiousness and $sigma_beta$ its standard deviation, which implies pervasive superspreading. This result allows us to estimate that in the early stages of the pandemic in the USA, over 81% of new cases were a result of the top 10% of most infectious individuals.
The recent global surge in COVID-19 infections has been fueled by new SARS-CoV-2 variants, namely Alpha, Beta, Gamma, Delta, etc. The molecular mechanism underlying such surge is elusive due to 4,653 non-degenerate mutations on the spike protein, which is the target of most COVID-19 vaccines. The understanding of the molecular mechanism of transmission and evolution is a prerequisite to foresee the trend of emerging vaccine-breakthrough variants and the design of mutation-proof vaccines and monoclonal antibodies. We integrate the genotyping of 1,489,884 SARS-CoV-2 genomes isolates, 130 human antibodies, tens of thousands of mutational data points, topological data analysis, and deep learning to reveal SARS-CoV-2 evolution mechanism and forecast emerging vaccine-escape variants. We show that infectivity-strengthening and antibody-disruptive co-mutations on the S protein RBD can quantitatively explain the infectivity and virulence of all prevailing variants. We demonstrate that Lambda is as infectious as Delta but is more vaccine-resistant. We analyze emerging vaccine-breakthrough co-mutations in 20 countries, including the United Kingdom, the United States, Denmark, Brazil, and Germany, etc. We envision that natural selection through infectivity will continue to be the main mechanism for viral evolution among unvaccinated populations, while antibody disruptive co-mutations will fuel the future growth of vaccine-breakthrough variants among fully vaccinated populations. Finally, we have identified the co-mutations that have the great likelihood of becoming dominant: [A411S, L452R, T478K], [L452R, T478K, N501Y], [V401L, L452R, T478K], [K417N, L452R, T478K], [L452R, T478K, E484K, N501Y], and [P384L, K417N, E484K, N501Y]. We predict they, particularly the last four, will break through existing vaccines. We foresee an urgent need to develop new vaccines that target these co-mutations.
Log in to be able to interact and post comments
comments
Fetching comments
Sign in to be able to follow your search criteria
